Category: Oncology/Hematology
United States Oncology/Hematology
-
2023 Global Cancer Diagnostics Market in the USA, Europe, Japan-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... and analysis not available from any other published source , including 2022 supplier strategies and shares by country, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists ... Read More
-
2023 North America Cancer Diagnostics Market in the USA, Canada, Mexico-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... information and analysis not available from any other published source , including 2022 supplier strategies and shares by country, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive ... Read More
-
2023 US Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent ... Read More
-
NA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (U.S., Canada, ... Read More
-
NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry ... Read More
-
NA Kidney Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type (Renal Cell Carcinoma, Clear cell renal cell carcinoma, non-clear cell renal cell carcinoma), Product (Platform-Based Products, Instrument based products, Kits and Reagents, and Other Consumables), Technology ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
... testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is ... Read More
-
2022 North America Immunoassay Analyzers and Reagents - USA, Canada, Mexico - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests Performed in Hospitals, Commercial/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Tests Performed in Hospitals, Commercial/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
-
NA Hereditary Cancer Testing Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029. Market Segmentation North America Hereditary Cancer Testing Market, By Test ... Read More
-
NA Lung Cancer Surgery Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation North America Lung Cancer Surgery Market, By ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
2022-2026 Global Cancer Diagnostics Market in the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of ... Read More
-
United States Liquid Biopsy Market, By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Others), By Technology (Multi-gene Parallel Analysis using NGS v/s Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The United States liquid biopsy market is projected to ... Read More
-
U.S. Digital Therapeutics Market - Industry Outlook and Forecast 2022-2027
... to the growth of the U.S. digital therapeutics market: Rise in Chronic Diseases and Need for Controlling Healthcare Costs Increase in Adoption of Healthcare Applications & Smart Wearables Rising Importance of A.I. in Digital Therapeutics ... Read More
-
2022 US Immunodiagnostic Analyzers and Reagents - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. The report explores future trends in the ... Read More
-
2022 Global Immunodiagnostic Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic market during the next five years. The report explores ... Read More
-
2022-2026 US Clinical Chemistry Market Database - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume ... Read More
-
2022-2026 Global Clinical Chemistry Market Database for the US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
U.S. Solid Tumor Testing Market - A Country Analysis: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032
... Overview The U.S. solid tumor testing market was estimated to be at $9,498.8 million in 2021, which is expected to grow with a CAGR of 6.19% during the forecast period 2022-2032 and reach $18,287.6 million ... Read More
-
2022-2026 Succeeding in the Global Hematology and Flow Cytometry Market: US, Europe, Japan - Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers
... This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report ... Read More
Research Assistance
